João Malato

Postdoctoral researcher @GIMM_Institute, @lgraca Lab and Immune-Stats Group

[CureME - UK ME/CFS Biobank @mecfsbiobank]

🩸 Since 2011, the UK ME/CFS Biobank has collected thousands of blood samples from #pwME.

🤔 But where do these samples go?

💙 This #MEAwarenessDay, we're highlight the pivotal role of global collaboration in driving ME/CFS research.

📖 Read more: https://t.co/72MZ7xQfRU

[Daniela @danielafcr_back]

Parabéns ao @sirpauperio e ao restante pessoal que se apresentou às primárias do Livre. Que possam agora fazer uma boa campanha, sem demasiado eurocornismo :)

[Liliana Borges @lilianapborges]

Depois de quase terem sido alteradas as regras das eleições primárias do Livre a meio do processo eleitoral, @sirpauperio, o candidato mais votado na primeira volta, confirmou a sua vitória na segunda volta das primárias.
https://t.co/MQNvwEGa9V

[João Malato @jtmalato]

@miguel_won @DavidMouro2 @LConraria O regulamento não só não é claro sobre o número definido de candidatos, como na 1a volta era possível escolher livremente 0–6 candidatos sem restrições. São tão demarcadas essas regulamentações e incentivos para votar em 6, que até o exemplo que incluíram apenas considerava 3.

[João Malato @jtmalato]

@TiagoALOMarques @LIVREpt https://t.co/TmukCRRIrA

[João Malato @jtmalato]

Found it! @CEstatisticAUL

[João Malato @jtmalato]

@TiagoALOMarques *You'res

[The Lancet Infectious Diseases @TheLancetInfDis]

New correspondence: Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months
https://t.co/CdgJgfqgXd

[Luis Graca @lgraca]

Happy to share our 1st publication of 2023! Hybrid immunity (protection against Omicron BA.5 infection acquired by vaccination + Omicron BA.1/BA.2 infection) is stable over 8 months. Data from the 🇵🇹registry.🧵1/12
https://t.co/CaLnuiZTa2
@IMMolecular @lgraca @TheLancetInfDis

[João Malato @jtmalato]

With 2023 around the corner, I thought I'd share my review of this past year. This video was presented at our last lab meeting of the year, as a proposed challenge from @nunosep1. Hope you all enjoy the final musical performance as much as my colleagues ;)
https://t.co/GrBBY7K6L4

[#NGSchool @NGSchoolEU]

#NGSchool is a fantastic community of computational biology enthusiasts and great science communicators! ‍👩‍🏫 Check what people say about #NGSchool2022 & #NGSymposium2022
👉 https://t.co/45WgkAOEXw And follow us to keep updated about upcoming events!

[#NGSchool @NGSchoolEU]

5th edition of #NGSchool2022: Machine Learning in Computational Biology is here!
program: https://t.co/xBwzazTSsP Big thanks to our speakers @szymongrabia @nunosep1 @LeopoldParts
@kzkedzierska @jtmalato @kasparmartens
@sienkieee @kjgeras @not_a_reptiloid & Ula Smyczyńska

[João Malato @jtmalato]

@ruisilrodrigues Mais que preparado! Muita força ✌️

[Luis Graca @lgraca]

Our most recent study was just made available in the NEJM: https://t.co/3W7itK7oEO
Hybrid immunity, with BA.1/BA.2 Omicron infection, confers significant protection against BA.5 infection.
Also as medRxiv preprint: https://t.co/b7ni4POUhw @medicina_lisboa @IMMolecular

[João Malato @jtmalato]

@HelenBranswell @kallmemeg @Tuliodna

[João Malato @jtmalato]

Our most recent preprint:
Vaccinated people with a BA.1 natural infection are protected from BA.5 infection. However, protection wanes rapidly (RR doubles in 5 months). This is critical for appraisal of new BA.1-based and bivalent vaccines.
(Portugal data, @DGSaude)
#COVID19

[Luis Graca @lgraca]

Waning of protection against Omicron BA.5 infection acquired by prior BA.1/BA.2 infection over the initial 5 months. Data from Portugal registry. Important for BA.1-based adapted vaccines. 🧵1/12
https://t.co/4XekcODZyg
@lgraca @IMMolecular @medicina_lisboa @DGSaude

[Eric Topol @EricTopol]

Rapid waning of immune protection by BA.1/BA.2 infections (mostly breakthroughs) against BA.5 infections
https://t.co/9XTirVPDa2 15-day intervals (A->E) in a Portugal nationwide report

[Luis Graca @lgraca]

Waning of protection against Omicron BA.5 infection acquired by prior BA.1/BA.2 infection over the initial 5 months. Data from Portugal registry. Important for BA.1-based adapted vaccines. 🧵1/12
https://t.co/4XekcODZyg
@lgraca @IMMolecular @medicina_lisboa @DGSaude

[Eric Topol @EricTopol]

In a Portugal, a country with a highly vaccinated population (>98% of a nationwide study population ≥ 2 shots), prior infection with Omicron BA.1/BA.2 protected well vs BA.5 breakthrough infections
https://t.co/tY1IHl3Pt9